Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

TriSalus Life Sciences (TLSIW) Competitors

TriSalus Life Sciences logo
$0.56 -0.12 (-17.00%)
As of 05/19/2026 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

TLSIW vs. DRTSW, ANZUW, HSCSW, BEATW, and LUCYW

Should you buy TriSalus Life Sciences stock or one of its competitors? MarketBeat compares TriSalus Life Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with TriSalus Life Sciences include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry.

How does TriSalus Life Sciences compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and TriSalus Life Sciences (NASDAQ:TLSIW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
TriSalus Life Sciences N/A N/A N/A

In the previous week, Alpha Tau Medical had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for TriSalus Life Sciences. Alpha Tau Medical's average media sentiment score of 0.00 equaled TriSalus Life Sciences'average media sentiment score.

Company Overall Sentiment
Alpha Tau Medical Neutral
TriSalus Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
TriSalus Life Sciences$44.88MN/AN/AN/AN/A

Summary

Alpha Tau Medical and TriSalus Life Sciences tied by winning 1 of the 2 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Anzu Special Acquisition Corp I?

TriSalus Life Sciences (NASDAQ:TLSIW) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

In the previous week, TriSalus Life Sciences' average media sentiment score of 0.00 equaled Anzu Special Acquisition Corp I'saverage media sentiment score.

Company Overall Sentiment
TriSalus Life Sciences Neutral
Anzu Special Acquisition Corp I Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88MN/AN/AN/AN/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

Summary

TriSalus Life Sciences beats Anzu Special Acquisition Corp I on 1 of the 1 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Heart Test Laboratories?

Heart Test Laboratories (NASDAQ:HSCSW) and TriSalus Life Sciences (NASDAQ:TLSIW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart Test Laboratories$8.67KN/AN/AN/AN/A
TriSalus Life Sciences$44.88MN/AN/AN/AN/A

In the previous week, Heart Test Laboratories' average media sentiment score of 0.00 equaled TriSalus Life Sciences'average media sentiment score.

Company Overall Sentiment
Heart Test Laboratories Neutral
TriSalus Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Heart Test LaboratoriesN/A N/A N/A
TriSalus Life Sciences N/A N/A N/A

Summary

TriSalus Life Sciences beats Heart Test Laboratories on 1 of the 1 factors compared between the two stocks.

How does TriSalus Life Sciences compare to HeartBeam?

TriSalus Life Sciences (NASDAQ:TLSIW) and HeartBeam (NASDAQ:BEATW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment.

In the previous week, TriSalus Life Sciences' average media sentiment score of 0.00 equaled HeartBeam'saverage media sentiment score.

Company Overall Sentiment
TriSalus Life Sciences Neutral
HeartBeam Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88MN/AN/AN/AN/A
HeartBeamN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
HeartBeam N/A N/A N/A

Summary

TriSalus Life Sciences beats HeartBeam on 1 of the 1 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCYW) and TriSalus Life Sciences (NASDAQ:TLSIW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk and dividends.

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
TriSalus Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$2.66MN/AN/AN/AN/A
TriSalus Life Sciences$44.88MN/AN/AN/AN/A

In the previous week, Innovative Eyewear had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 1 mentions for Innovative Eyewear and 0 mentions for TriSalus Life Sciences. Innovative Eyewear's average media sentiment score of 0.88 beat TriSalus Life Sciences' score of 0.00 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company Overall Sentiment
Innovative Eyewear Positive
TriSalus Life Sciences Neutral

Summary

Innovative Eyewear beats TriSalus Life Sciences on 2 of the 3 factors compared between the two stocks.

Get TriSalus Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLSIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLSIW vs. The Competition

Export
MetricTriSalus Life SciencesMedical Devices IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.10B$6.24B$12.23B
Dividend YieldN/A2.67%2.80%5.32%
P/E RatioN/A13.9320.7825.05
Price / SalesN/A130.10531.2172.66
Price / CashN/A15.9943.0954.25
Price / BookN/A4.499.816.83
Net IncomeN/A$144.75M$3.55B$335.69M
7 Day Performance-25.17%-0.41%-2.11%-2.15%
1 Month Performance-33.53%0.85%-4.14%-2.47%
1 Year Performance-60.49%5.48%28.35%27.13%

TriSalus Life Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLSIW
TriSalus Life Sciences
N/A$0.57
-17.0%		N/A-55.9%$0.00$44.88MN/A106
DRTSW
Alpha Tau Medical
N/A$1.80
+2.3%		N/A+1,168.9%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.07
flat		N/A+7.6%$0.00N/AN/A2
HSCSW
Heart Test Laboratories
N/A$0.06
+0.3%		N/A+42.6%$0.00$8.67KN/A10
BEATW
HeartBeam
N/A$0.08
-10.1%		N/A-81.3%$0.00N/AN/A5

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:TLSIW) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book attached
Veteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...
Profits Run | Sponsoredtc pixel
The one number Musk can't hide in the S-1
When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...
Behind the Markets | Sponsoredtc pixel
He doesn't buy gold. He just profits from it.
Former hedge fund manager Larry Benedict generated $274 million in profits - and Barron's ranked his fund in t...
Brownstone Research | Sponsoredtc pixel
How to Access Elon’s “Monster” Interest Rate
Most Americans earn just 0.4% on their savings - that's $40 a year on $10,000. A new banking alternative is of...
InvestorPlace | Sponsoredtc pixel
The “tell” for the end of the AI boom
The real question about AI stocks in 2026 isn't whether to own them - it's knowing exactly when to get in and ...
Stansberry Research | Sponsoredtc pixel
BIGGER than the SpaceX IPO?
Jon Najarian believes the SpaceX IPO - potentially arriving as soon as June 12th - may not even be the biggest...
Banyan Hill Publishing | Sponsoredtc pixel
After June 1, don't say I didn't warn you
Macroeconomic Strategist Dr. Mark Skousen of The Oxford Club says one date should be at the top of every inves...
The Oxford Club | Sponsoredtc pixel